Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04432376 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety Study of Miconazole Oil Versus Vehicle on Fungal Infection of the Ear Canal (Otomycosis)
A Phase 2 study, sponsored by Hill Dermaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 382
- Enrollment target
NCT04432376 is a Phase 2 study that has completed, run by Hill Dermaceuticals. The registered enrollment target is 382 participants.
The verdict
NCT04432376, a Phase 2 study, has completed, sponsored by Hill Dermaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 382 participants
- Enrollment target
Study Summary
This study involves two portions, a randomized, double-blind portion and an open-label portion, to evaluate the efficacy and safety of Miconazole oil 2% versus its Vehicle in the treatment of fungal infection of the outer ear canal (Otomycosis). The subjects randomized in the first portion of the study will have active fungal infection of the ear(s) and will be treated with either Miconazole Oil or the Vehicle for 14 days twice daily, 5 drops into the affected ear(s) per dose. The subjects enrolled in the open-label portion of the study may or may not have active fungal infection of the ear(s), and will be given the Miconazole Oil active drug following the same application of 5 drops into the ear(s) twice daily for 14 days. The intention of the study is to evaluate the efficacy of Miconazole Oil on fungal infection of the ears when applied using 5 drops into the ear(s) twice daily for 14 days continuously. This study also intends to show safety of Miconazole Oil 5 drops into each ear twice a day for 14 consecutive days.
Interventions
- DRUG miconazole 2% oil
- DRUG vehicle oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 382 participants |
| Start Date | 2020-07-08 |
| Est. Completion | 2021-11-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04432376
The ClinicalTrials.gov registry entry for NCT04432376 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 382 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hill Dermaceuticals, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which miconazole 2% oil is the first listed.
NCT04432376 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04432376 about?
NCT04432376 is a clinical study titled "Efficacy and Safety Study of Miconazole Oil Versus Vehicle on Fungal Infection of the Ear Canal (Otomycosis)". This study involves two portions, a randomized, double-blind portion and an open-label portion, to evaluate the efficacy and safety of Miconazole oil 2% versus its Vehicle in the treatment of fungal infection of the outer ear canal (Otomycosis). The subjects randomized in the first portion of the st...
What is the current status of trial NCT04432376?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 382 participants. The study started on 2020-07-08. Estimated completion is 2021-11-01.
What interventions are being tested in trial NCT04432376?
The interventions under investigation include: miconazole 2% oil (DRUG), vehicle oil (DRUG).
Who is sponsoring clinical trial NCT04432376?
This trial is sponsored by Hill Dermaceuticals, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.